Finance

Beta
Lists
REMEDY:HEL
Remedy Entertainment Oyj
€13.54
-3.84%
(-0.54) 1D
Jul 7, 6:29:57 PM GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for REMEDY...
Open
€14.50
High
€14.50
Low
€12.82
Mkt. cap
184.69M
Avg. vol.
9.23K
Volume
981.24K
52-wk high
€17.26
52-wk low
€11.06
EPS
-€0.97
Shares outstanding
13.64M
No. of employees
391
Open
€14.50
High
€14.50
Low
€12.82
Mkt. cap
184.69M
Avg. vol.
9.23K
Volume
981.24K
52-wk high
€17.26
52-wk low
€11.06
EPS
-€0.97
Shares outstanding
13.64M
No. of employees
391
News stories
From sources across the web
Profile
Remedy Entertainment Oyj, trading internationally as Remedy Entertainment Plc, is a Finnish video game developer based in Espoo. Notable games the studio has developed include the first two entries in the Max Payne franchise, Alan Wake, Quantum Break, and Control. Sam Lake, Remedy's creative director, has represented the company on numerous occasions. Founded in August 1995 by members of demoscene group Future Crew, Remedy Entertainment created its first game, Death Rally, in a team member's basement. Apogee Software served as the game's publisher, and continued to be involved in the production of its next title, Max Payne, which received critical acclaim upon release. The game was followed by a sequel, Max Payne 2: The Fall of Max Payne, released by Rockstar Games. After spending seven years working on the Max Payne franchise, the developer decided to create a new intellectual property called Alan Wake. This title was once suspected to be vaporware because of the length of time it took to produce and release. It gained a cult following when it was released in 2010, by Microsoft Game Studios, though at the time its sales were not enough to justify the production of a sequel. Wikipedia
About Remedy Entertainment Oyj
CEO-
Employees391
FoundedAug 18, 1995
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
16.92M
12.16M
17.04M
13.14M
Cost of goods sold
3.16M
2.40M
4.23M
907.00K
Cost of revenue
3.16M
2.40M
4.23M
907.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.43M
5.84M
9.52M
6.34M
Operating expense
14.21M
26.18M
-2.83M
11.20M
Total operating expenses
17.38M
28.58M
1.40M
12.11M
Operating income
-460.00K
-16.42M
15.64M
1.03M
Other non operating income
-
-
621.00K
-
EBT including unusual items
-561.00K
-16.70M
453.00K
752.00K
EBT excluding unusual items
-561.00K
-16.70M
15.37M
752.00K
Income tax expense
7.00K
-3.24M
52.00K
276.00K
Effective tax rate
-1.25%
19.42%
11.48%
36.70%
Other operating expenses
3.12M
3.23M
-565.00K
2.96M
Net income
-568.00K
-13.45M
401.00K
476.00K
Net profit margin
-3.36%
-110.68%
2.35%
3.62%
Earnings per share
-0.04
-0.99
0.03
0.04
Interest and investment income
458.00K
271.00K
40.00K
13.00K
Interest expense
-559.00K
-543.00K
-703.00K
-290.00K
Net interest expenses
-101.00K
-272.00K
-663.00K
-277.00K
Depreciation and amortization charges
4.67M
17.11M
-11.78M
1.90M
EBITDA
952.00K
-15.83M
16.15M
1.51M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more